Strategic Partnerships Pursue collaboration with major medical centers and health systems leveraging Polarean’s Xenon MRI platform, as evidenced by recent supply agreements and integrations (e.g., UVA Health, SimonMed, KU Medical Center) to expand clinical adoption and joint reimbursement discussions.

Clinical Adoption Capitalize on growing presence in pulmonary medicine conferences and RIS events (ATS 2025, RIS) to showcase FDA-approved Xenon MRI and build awareness among pulmonologists, radiologists, and hospital procurement teams to accelerate trialing and purchasing decisions.

Expansion Financing Leverage recent financing and scale-up news to secure partnerships with hospitals and imaging centers for equipment upgrades and service contracts, targeting mid to large-capacity imaging facilities seeking noninvasive, radiation-free lung imaging capabilities.

Integrated Solutions Position the full Xenon MRI platform—including gas blend, hyperpolarization system, software, and accessories—as a turnkey solution with training and clinical support, addressing procurement preferences for integrated, future-proof pulmonary imaging workflows.

Key Leadership Engage Chief Medical Advisor and medical leadership in co-development of clinical protocols, case studies, and payer-friendly reimbursement narratives to strengthen credibility, drive clinical evidence generation, and accelerate adoption among reimbursements and hospital committees.